Responses
EULAR 2014: Speakers Abstracts
Speaker Presentations. Therapy of refractory autoimmune diseases
SP0189 Induction of Remission by Low-Dose IL-2-Therapy in One SLE Patient with Increased Disease Activity Refractory to Standard Therapies
Compose a Response to This Article
Other responses
No responses have been published for this article.